HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Tsutomu Takeuchi Selected Research
Tsutomu Takeuchi Research Topics
Disease
263
Rheumatoid Arthritis
11/2022 - 06/2003
46
Infections
07/2022 - 08/2002
22
Immunoglobulin G4-Related Disease
07/2022 - 01/2012
22
Systemic Lupus Erythematosus (Libman-Sacks Disease)
05/2022 - 09/2003
21
Interstitial Lung Diseases (Interstitial Lung Disease)
01/2022 - 09/2005
17
Herpes Zoster
07/2022 - 01/2016
15
Rheumatic Diseases (Rheumatism)
04/2022 - 01/2007
14
Autoimmune Diseases (Autoimmune Disease)
01/2022 - 08/2005
13
Inflammation (Inflammations)
05/2022 - 08/2003
11
Necrosis
01/2021 - 07/2011
10
Neoplasms (Cancer)
05/2022 - 12/2002
9
Lupus Nephritis
07/2022 - 01/2007
9
Arthritis (Polyarthritis)
01/2022 - 01/2006
9
Adult-Onset Still's Disease
01/2022 - 03/2012
9
Fever (Fevers)
05/2021 - 09/2005
9
Pain (Aches)
01/2021 - 05/2012
9
Cysts
06/2012 - 09/2002
8
Pneumonia (Pneumonitis)
03/2021 - 01/2007
7
Opportunistic Infections (Opportunistic Infection)
01/2021 - 01/2005
7
Drug-Related Side Effects and Adverse Reactions
05/2020 - 11/2010
7
Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia)
11/2012 - 01/2007
6
Lymphoproliferative Disorders (Lymphoproliferative Disorder)
01/2022 - 02/2007
6
Systemic Scleroderma (Systemic Sclerosis)
10/2021 - 01/2007
6
Polymyalgia Rheumatica (Rhizomelic Pseudopolyarthritis)
10/2021 - 01/2015
5
Vasculitis (Vasculitides)
07/2022 - 01/2021
5
Connective Tissue Diseases (Connective Tissue Disease)
11/2021 - 03/2013
5
Disease Progression
11/2021 - 12/2017
5
Myositis (Idiopathic Inflammatory Myopathies)
01/2021 - 09/2005
5
Nasopharyngitis
01/2019 - 06/2016
5
Arthralgia (Joint Pain)
11/2018 - 07/2011
5
Amebiasis (Amoebiasis)
02/2006 - 08/2003
4
Psoriatic Arthritis
07/2022 - 08/2017
4
Dermatomyositis (Dermatopolymyositis)
01/2022 - 09/2005
4
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
11/2021 - 01/2020
4
Juvenile Arthritis (Juvenile Idiopathic Arthritis)
10/2021 - 08/2017
4
Mixed Connective Tissue Disease (MCTD)
01/2021 - 10/2012
4
Joint Diseases (Joint Disease)
12/2017 - 10/2013
4
Communicable Diseases (Infectious Diseases)
01/2016 - 10/2003
4
Lung Diseases (Lung Disease)
10/2015 - 11/2012
Drug/Important Bio-Agent (IBA)
81
Methotrexate (Mexate)
FDA Link
Generic
11/2022 - 12/2004
44
Biological Products
IBA
05/2022 - 01/2005
43
tocilizumab (atlizumab)
FDA Link
10/2022 - 09/2007
34
Infliximab (Remicade)
FDA Link
07/2022 - 01/2005
31
Antirheumatic Agents (DMARD)
IBA
11/2021 - 01/2006
28
Glucocorticoids
IBA
01/2022 - 02/2003
26
Adalimumab (Humira)
FDA Link
02/2022 - 06/2012
24
Interleukin-6 (Interleukin 6)
IBA
01/2022 - 06/2004
24
Monoclonal Antibodies
IBA
07/2021 - 10/2003
21
Immunoglobulin G (IgG)
IBA
07/2022 - 01/2005
21
Biomarkers (Surrogate Marker)
IBA
09/2021 - 01/2009
21
Etanercept (Enbrel)
FDA Link
03/2021 - 12/2002
20
Abatacept (Orencia)
FDA Link
04/2022 - 03/2013
18
Cytokines
IBA
01/2022 - 02/2003
17
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
11/2022 - 01/2005
16
Pharmaceutical Preparations
IBA
02/2022 - 10/2002
15
baricitinib
IBA
01/2022 - 01/2017
14
C-Reactive Protein
IBA
05/2021 - 01/2008
13
Janus Kinase Inhibitors
IBA
07/2022 - 01/2016
12
Interleukins
IBA
01/2022 - 11/2013
12
Prednisolone (Predate)
FDA Link
Generic
01/2022 - 09/2005
12
Autoantibodies
IBA
05/2021 - 01/2011
11
peficitinib
IBA
07/2022 - 06/2016
11
Antibodies
IBA
01/2021 - 02/2003
11
Certolizumab Pegol
FDA Link
03/2020 - 07/2014
11
Adrenal Cortex Hormones (Corticosteroids)
IBA
09/2019 - 09/2005
11
Enzymes
IBA
11/2018 - 01/2004
10
Tacrolimus (Prograf)
FDA Link
Generic
11/2021 - 02/2009
10
Tumor Necrosis Factor Inhibitors
IBA
07/2021 - 07/2011
9
Rituximab (Mabthera)
FDA Link
01/2022 - 01/2007
9
Proteins (Proteins, Gene)
FDA Link
05/2021 - 03/2002
8
tofacitinib
IBA
10/2022 - 07/2015
8
Antineutrophil Cytoplasmic Antibodies (ANCA)
IBA
11/2021 - 01/2011
7
GLPG0634
IBA
04/2022 - 01/2019
7
Denosumab
FDA Link
11/2021 - 06/2016
7
sirukumab
IBA
01/2021 - 06/2017
7
golimumab
FDA Link
01/2020 - 06/2012
7
Interleukin-6 Receptors (Interleukin 6 Receptor)
IBA
01/2020 - 01/2009
6
Immunosuppressive Agents (Immunosuppressants)
IBA
11/2021 - 06/2005
6
upadacitinib
IBA
06/2021 - 01/2020
6
Antigens
IBA
01/2021 - 03/2004
6
Janus Kinases
IBA
10/2020 - 06/2017
6
Messenger RNA (mRNA)
IBA
06/2012 - 09/2003
5
omega-Chloroacetophenone (Mace)
IBA
04/2022 - 01/2019
5
Steroids
IBA
01/2022 - 05/2015
5
Cyclophosphamide (Cytoxan)
FDA Link
Generic
11/2021 - 09/2005
5
Leflunomide (Arava)
FDA Link
Generic
01/2020 - 01/2008
4
Biosimilar Pharmaceuticals
IBA
07/2022 - 06/2017
4
Interleukin-4 (Interleukin 4)
IBA
01/2022 - 09/2010
4
Cyclosporine (Ciclosporin)
FDA Link
Generic
11/2021 - 09/2005
4
ametantrone (HAQ)
IBA
01/2021 - 01/2009
4
DNA (Deoxyribonucleic Acid)
IBA
01/2020 - 06/2003
4
Sulfasalazine (Azulfidine)
FDA Link
Generic
01/2020 - 10/2013
4
beta-cyclodextrin tetradecasulfate (CTDS)
IBA
01/2020 - 10/2012
4
Non-Steroidal Anti-Inflammatory Agents (NSAIDs)
IBA
04/2018 - 07/2011
4
zeta chain antigen T cell receptor (TCR zeta chain)
IBA
08/2005 - 09/2003
3
CT-P13
IBA
07/2022 - 01/2015
3
Anti-Citrullinated Protein Antibodies
IBA
04/2022 - 06/2014
Therapy/Procedure
83
Therapeutics
11/2022 - 08/2002
4
Aftercare (After-Treatment)
05/2018 - 01/2011
4
Biological Therapy
05/2015 - 11/2010